Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Greenstone – Recall of diphenoxylate/atropine
November 16, 2017 – The FDA announced a consumer-level recall of some lots of Greenstone’s diphenoxylate/atropine tablets because product from these lots has the potential to be super potent or sub potent.
